Trans-inhibition of HIV-1 by a long hairpin RNA expressed within the viral genome

被引:1
作者
Konstantinova, Pavlina
ter Brake, Olivier
Haasnoot, Joost
de Haan, Peter
Berkhout, Ben
机构
[1] Univ Amsterdam, Lab Expt Virol, Dept Med Microbiol, CINIMA,Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Viruvat BV, NL-2333 AL Leiden, Netherlands
来源
RETROVIROLOGY | 2007年 / 4卷
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Human immunodeficiency virus type 1 (HIV-1) can be inhibited by means of RNA silencing or interference (RNAi) using synthetic short interfering RNAs (siRNAs) or gene constructs encoding short hairpin RNAs (shRNAs) or long hairpin RNAs (lhRNAs). The use of siRNA and shRNA as antiviral therapeutic is limited because of the emergence of viral escape mutants. This problem is theoretically prevented by intracellular expression of lhRNAs generating multiple siRNAs that target the virus simultaneously, thus reducing the chance of viral escape. However, gene constructs encoding lhRNA molecules face problems with delivery to the right cells in an infected individual. In order to solve this problem, we constructed an HIV-1 variant with a 300 bp long hairpin structure in the 3' part of the genome corresponding to the Nef gene (HIV-lhNef). Results: Intriguingly, HIV-lhNef potently inhibited wild-type HIV-1 production in trans. However, HIV-lhNef demonstrated a severe production and replication defect, which we were able to solve by selecting spontaneous virus variants with truncated hairpin structures. Although these escape variants lost the ability to trans-inhibit HIV-1, they effectively outgrew the wild-type virus in competition experiments in SupT1 cells. Conclusion: Expression of the lhNef hairpin within the HIV-1 genome results in potent transinhibition of wild-type HIV-1. Although the mechanism of trans-inhibition is currently unknown, it remains of interest to study the molecular details because the observed effect is extremely potent. This may have implications for the development of virus strains to be used as live-attenuated virus vaccines.
引用
收藏
页数:14
相关论文
共 43 条
[1]   RNA silencing of dengue virus type 2 replication in transformed C6/36 mosquito cells transcribing an inverted-repeat RNA derived from the virus genome [J].
Adelman, ZN ;
Sanchez-Vargas, I ;
Travanty, EA ;
Carlson, JO ;
Beaty, BJ ;
Blair, CD ;
Olson, KE .
JOURNAL OF VIROLOGY, 2002, 76 (24) :12925-12933
[2]   Escape from the interferon response associated with RNA interference using vectors that encode long modified hairpin-RNA [J].
Akashi, H ;
Miyagishi, M ;
Yokota, T ;
Watanabe, T ;
Hino, T ;
Nishina, K ;
Kohara, M ;
Taira, K .
MOLECULAR BIOSYSTEMS, 2005, 1 (5-6) :382-390
[3]   Bispecific short hairpin siRNA constructs targeted to CD4, CXCR4, and CCR5 confer HIV-1 resistance [J].
Anderson, J ;
Banerjea, A ;
Akkina, R .
OLIGONUCLEOTIDES, 2003, 13 (05) :303-312
[4]   Stabilization of the U5-leader stem in the HIV-1 RNA genome affects initiation and elongation of reverse transcription [J].
Beerens, N ;
Groot, F ;
Berkhout, B .
NUCLEIC ACIDS RESEARCH, 2000, 28 (21) :4130-4137
[5]  
Berkhout B, 2004, CURR OPIN MOL THER, V6, P141
[6]   The interplay between virus infection and the cellular RNA interference machinery [J].
Berkhout, Ben ;
Haasnoot, Joost .
FEBS LETTERS, 2006, 580 (12) :2896-2902
[7]   Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins [J].
Boden, D ;
Pusch, O ;
Silbermann, R ;
Lee, F ;
Tucker, L ;
Ramratnam, B .
NUCLEIC ACIDS RESEARCH, 2004, 32 (03) :1154-1158
[8]   Human immunodeficiency virus type 1 escape from RNA interference [J].
Boden, D ;
Pusch, O ;
Lee, F ;
Tucker, L ;
Ramratnam, B .
JOURNAL OF VIROLOGY, 2003, 77 (21) :11531-11535
[9]   Delivery of short hairpin RNA sequences by using a replication-competent avian retroviral vector [J].
Bromberg-White, JL ;
Webb, CP ;
Patacsil, VS ;
Miranti, CK ;
Williams, BO ;
Holmen, SL .
JOURNAL OF VIROLOGY, 2004, 78 (09) :4914-4916
[10]   Inhibition of viral gene expression and replication in mosquito cells by dsRNA-triggered RNA interference [J].
Caplen, NJ ;
Zheng, ZL ;
Falgout, B ;
Morgan, RA .
MOLECULAR THERAPY, 2002, 6 (02) :243-251